GlassScriptPhysician profile
Allison M Kos
NPI 1518916931
$1,533.99
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $219 · 2021: $14.33 · 2022: $117 · 2023: $317 · 2024: $92.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $173.41 | 2019-2023 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $165.27 | 2019-2023 | |
| Abbvie INC. | $150.46 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.63 | 2019-2020 | |
| Lilly USA, LLC | $122.58 | 2019-2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.74 | 2019 | |
| Glaxosmithkline, LLC. | $82.08 | 2019-2024 | Bexsero |
| Gilead Sciences, INC. | $79.65 | 2019-2020 | |
| Astellas Pharma US INC | $78.93 | 2019-2023 | Myrbetriq |
| Sanofi Pasteur INC. | $60.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $54.40 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.60 | 2019-2023 | Trintellix |
| Exact Sciences Corporation | $33.82 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $32.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.03 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $31.01 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.13 | 2019 | |
| Sumitomo Pharma America, INC. | $22.10 | 2023 | Myfembree |
| Lundbeck LLC | $20.90 | 2024 | Rexulti |
| Ironwood Pharmaceuticals, INC | $17.99 | 2024 | |
| Roche Diagnostics Corporation | $17.84 | 2019 | |
| Lupin INC. | $14.78 | 2019 | |
| Allergan, INC. | $13.58 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Kos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.